MedElevator Войти в исследования
← Поиск публикаций

DOI 10.24875/acm.21000185

Медицинская библиотека · Archivos de cardiologia de Mexico · 2022

[Differences among renin-angiotensin system inhibitor drugs in prognosis of hypertense patients with COVID-19].

Negreira-Caamaño Martín, Martínez-Del-Río Jorge, Nieto-Sandoval-Martín-de-la-Sierra Patricia, Águila-Gordo Daniel, Mateo-Gómez Cristina, Rodríguez-Martínez Marta, Salas-Bravo Daniel, Piqueras-Flores Jesús

Аннотация на английскомСтатьяПеревод в очереди

Аннотация

INTRODUCTION

Concerns have been raised about Renin-angiotensin system inhibitors (RASi) in patients with COVID-19. Although recent trials have proved its security, evidence regarding intrinsic differences between RASi is lacking, especially in patients with arterial hypertension. Our objective was to analyse the prognosis of hypertense patients who received angiotensin converting enzyme inhibitors (ACEi) or angiotensin-2 receptor blockers (ARBs) and were hospitalized due to COVID-19.

MATERIALS AND

METHODS

392 consecutive patients with hypertension and COVID-19 were analyse. Incidence of the combined event (death or mechanical ventilation need) was the primary endpoint. Secondary, incidence of each event and time to event were analysed.

RESULTS

155 received ACEi and 237 ARBs. During the hospitalization, the combined event was observed in the 31,6 % of patients. No differences were observed between those previously treated with ACEi and ARBs (33.5 vs. 30.9%; p = 0.51). In the survival analysis, no differences were observed regarding time to combined event (p = 0.91). In-hospital mortality was similar in both groups (32.3 vs. 29.1%; p = 0.51), as well as the need of mechanical ventilation (3.2 vs. 5.9%; p = 0.23).

CONCLUSIONS

The type of RASi was not associated with in-hospital major events in patients with arterial hypertension hospitalized due to COVID-19.

Для цитирования: Negreira-Caamaño Martín, Martínez-Del-Río Jorge, Nieto-Sandoval-Martín-de-la-Sierra Patricia, Águila-Gordo Daniel, Mateo-Gómez Cristina, Rodríguez-Martínez Marta, Salas-Bravo Daniel, Piqueras-Flores Jesús. [Differences among renin-angiotensin system inhibitor drugs in prognosis of hypertense patients with COVID-19].. Archivos de cardiologia de Mexico. 2022. DOI: 10.24875/acm.21000185.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.